NEW YORK, May 23 – Genomics stocks, many of which hit new lows at the end of March or beginning of April, appear to be gaining momentum, pulled higher by the market's overall rise and renewed investor confidence following the Internet crash, analysts said Wednesday.

“Total stock is up,” said Winton Gibbons, a analyst at William Blair of Chicago. But he noted that people are also separating genome stocks out from the negative association with Internet stocks.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Consulting company McKinsey says diagnostics companies will have to combine genomic data analysis, electronic medical records, effective reimbursement strategies, and regulatory compliance in order to win.

A new report has found that researchers in Africa are still heavily dependent on funding from organizations in the US, Europe, and China, Nature News says.

An article in The Atlantic argues that the progress being made in science isn't keeping pace with the money and time being spent on research.

In Science this week: a CRISPR screen identifies sideroflexin 1 as a requisite component of one-carbon metabolism, and more.